packageLapatinib
lapatinib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Lapatinib is a HER2-targeting protein kinase inhibitor used to treat certain breast cancers, including rare breast tumors. It is approved and authorised in the European Union for breast cancer, and is also being investigated for other uses.
Summary written by glm-5.3-flash from Wikidata Q420323 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | lapatinib |
| ATC codes: | L01EH01 |
| DrugBank: | DB01259 |
| PubChem CID: | 208908 |
| ChEBI: | 49603 |
| Wikidata: | Q420323 |
| formula: | C29H26ClFN4O4S |
| molar mass: | 581.059 g/mol (PubChem CID 208908) |
| logP: | 5.1 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |